Eye Can See Optical | |
351 Main St, Laurel, MD 20707-4131 | |
(301) 802-7527 | |
(301) 490-5368 |
Full Name | Eye Can See Optical |
---|---|
Type | Facility |
Speciality | Technician/technologist - Optician |
Location | 351 Main St, Laurel, Maryland |
Accepts Medicare Assignments | Does not participate in Medicare Program. The facility may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1821330119 | NPI | - | NPPES |
422606100 | Medicaid | MD |
Mailing Address | Practice Location Address |
---|---|
Eye Can See Optical 351 Main St, Laurel, MD 20707-4131 Ph: (301) 802-7527 | Eye Can See Optical 351 Main St, Laurel, MD 20707-4131 Ph: (301) 802-7527 |
News Archive
eClinicalWorks, a market leader in ambulatory clinical systems, today announced that Central Ohio Primary Care Physicians (COPCP), the second largest privately-owned primary care group in the United States, has chosen eClinicalWorks comprehensive electronic health records (EHR) solution for its 230 physicians across 44 practices.
Terahertz (THz) radiation, a slice of the electromagnetic spectrum that occupies the middle ground between microwaves and infrared light, is rapidly finding important uses in medical diagnostics, security, and scientific research. As scientists and engineers find evermore practical uses for this form of radiation, questions persist about its potential human health risks.
An innovative program in Bangladesh that caused unusually large reductions in child malnutrition will come to life May 9 at an event featuring experts from the poverty-fighting organization CARE and the U.S. Agency for International Development (USAID).
Merck & Co., Inc. today said it will appeal a decision by the U.S. District Court for the Southern District of New York that reduced the jury verdict from $8 million to $1.5 million but denied Merck's request for judgment in its favor or a new trial in the case of Boles v. Merck, a retrial of a federal FOSAMAX case.
President Donald Trump repeatedly talks tough about reining in the pharmaceutical industry, but his administration's efforts to lower drug prices are shrouded in secrecy.
› Verified 7 days ago